MIS-C pathogenesis involves dysregulation of the innate immune system, primarily accentuating the IL-1β pathway and elevating pro-inflammatory cytokine levels. The gene discussed is IL1B; the disease is COVID-19–associated multisystem inflammatory syndrome in children.